Rentschler Biopharma: Your trusted partner for high-quality biopharmaceuticals.
Rentschler Biopharma enables your product’s success by translating medical research into outstanding biopharmaceuticals. They are a trusted partner for high-quality biopharmaceuticals - from concept to market.
Rentschler Biopharma is united through the passion for what they do. They make a contribution to the global availability of biopharmaceuticals. As a full-service CDMO, they are your outsourcing partner for bioprocess development and cGMP manufacturing as well as for the elaboration of your products’ approval strategies from clinical studies to market approval. They guarantee best-fit solutions for your biopharmaceutical products, with quality always paramount.
This commitment is reflected in their outstanding regulatory track record as well as their exceptional client-oriented project management and regulatory support. Their strength lies in their experience with highly complex molecules. Fusion proteins, recombinant enzymes, monoclonal and multi-specific antibodies, as well as mRNA-based vaccines are among the 120 different formats that they have handled. Their track record of more than 300 molecules for 160 clients worldwide translates to unrivaled experience along the entire biopharmaceutical value chain.
With their roots in a local pharmacy founded in 1872, Rentschler Biopharma today is a family-owned and independent company with 50 years of proven scientific expertise in biotechnology. The company structure guarantees rapid decision-making as well as efficient and smooth-running processes to adhere to project timelines. As a biotechnology pioneer, Rentschler Biopharma built a reputation through the early development of different interferon products (Fiblaferon, Polyferon). In 1997, they pioneered biopharma outsourcing and were one of the world’s first CDMOs.
Today, their attention is firmly focused on their customers' needs, from their headquarters in Laupheim, Germany, and their site in Milford, MA, USA. In Stevenage, UK, Rentschler Biopharma has launched a company dedicated to cell and gene therapies, Rentschler ATMP Ltd. Rentschler Biopharma offers end-to-end solutions and are your trusted outsourcing partner of choice.